ARCA biopharma, Inc. (ABIO) Covered Calls

You can sell covered calls on ARCA biopharma, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ABIO (prices last updated Fri 4:16 PM ET):

ARCA biopharma, Inc. (ABIO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.58 +0.10 3.27 3.55 85K - 0.0
Covered Calls For ARCA biopharma, Inc. (ABIO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 2.5 0.90 2.65 -5.7% -94.6%
Jun 21 2.5 0.50 3.05 -18.0% -115.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ARCA biopharma, Inc. operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.